INFORMATICS 

Cao L, Huang YS, Getz KD, Seif AE, Ruiz J, Miller TP, Fisher BT, Aplenc R, Li Y. Applying machine
learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using
administrative data. Pediatric Blood Cancer. 2024 Mar;71(3):e30858. PubMed PMID: 38189744.​

​

Cao L, Huang YS, Wu C, Getz K, Miller TP, Ruiz J, Fisher BT, Seif AE, Aplenc R, Li Y. Leveraging
machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database. Pediatr Blood Cancer. 2023 May;70(5):e30260. PubMed Central PMCID: PMC10402395.​​​​

​

​Chow EJ, Aplenc R, Vrooman LM, Doody DR, Huang YV, Aggarwal S, Armenian SH, Baker KS, Bhatia
S, Constine LS, Freyer DR, Kopp LM, Leisenring WM, Asselin BL, Schwartz CL, Lipshultz SE. Late
health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group. Cancer. 2022 Feb 15;128(4):788-796. PubMed Central PMCID: PMC8792306.​

​

Aplenc R, Fisher BT, Huang YS, Li Y, Alonzo TA, Gerbing RB, Hall M, Bertoch D, Keren R, Seif AE,
Sung L, Adamson PC, Gamis A. Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group. Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2(Suppl 2):37-43. PubMed Central PMCID: PMC3359580.

​